Holen Sie sich die Stockscreener-App
18.00
3.85%
-0.72
Vorhandelsmarkt:
18.08
0.08
+0.44%
Clearpoint Neuro Inc Aktie (CLPT) Neueste Nachrichten
ClearPoint Neuro CEO Burnett sells $387,600 in company shares - Investing.com
Form 4 Clearpoint Neuro Inc For: 1 July By Investing.com - Investing.com Canada
ClearPoint Neuro CEO Burnett sells $387,600 in company shares By Investing.com - Investing.com Canada
ClearPoint Neuro (CLPT) CEO exercises options and sells 20,000 shares under 10b5-1 plan - Stock Titan
Price to sales forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Price to book forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Price to earnings forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Enterprise value to EBITDA forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
(CLPT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Director sale notice, CLPT (NASDAQ: CLPT) — 20,000 shares via option exercise - Stock Titan
Enterprise value to EBIT forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Enterprise value to revenue forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
ClearPoint Neuro, Inc. Actuals & Estimates (NASDAQ:CLPT) - TradingView
CLPT Forecast — Price Target — Prediction for 2027 - TradingView
Compared to estimates, ClearPoint Neuro (CLPT) Q1 earnings: A look at key metrics - MSN
ClearPoint Neuro, Inc. (CLPT) reports Q1 loss, lags revenue estimates - MSN
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Announces Target Price $30 - Moomoo
Clearpoint Neuro Inc (CLPT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), uniQure (QURE) - The Globe and Mail
ClearPoint Neuro (CLPT) CEO sells 61,843 shares after exercising options - Stock Titan
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating - Moomoo
Stifel Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $25 - Moomoo
Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), Tyra Bioscience (TYRA) - The Globe and Mail
ClearPoint Neuro (CLPT) surges 26.0%: Is this an indication of further gains? - MSN
Liquidity Mapping Around (CLPT) Price Events - Stock Traders Daily
CLPT Maintained by B. Riley Securities -- Price Target Raised to $30 - GuruFocus
ClearPoint Neuro Is Maintained at Buy by B. Riley Securities - Moomoo
B. Riley Securities Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $30 - Moomoo
Clearpoint Neuro Inc (CLPT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ClearPoint Neuro: AMT-130's FDA Reversal Revives The Bull Case (NASDAQ:CLPT) - Seeking Alpha
B. Riley Adjusts ClearPoint Neuro Price Target to $30 From $20, Maintains Buy Rating - marketscreener.com
ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains? - Yahoo Finance
Clearpoint Neuro Inc (CLPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Clearpoint Neuro Inc (CLPT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Clearpoint Neuro Inc (CLPT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Clearpoint Neuro Inc (CLPT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Clearpoint Neuro Inc (CLPT) Institutional Confidence - TradingKey
Clearpoint Neuro Inc (CLPT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Clearpoint Neuro Inc (CLPT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
[144] ClearPoint Neuro, Inc. SEC Filing - Stock Titan
ClearPoint Neuro (CLPT) Sees Significant Pre-Market Gains Following Partner Announcement - GuruFocus
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
ClearPoint Neuro Shares Jump as FDA Progress for UniQure Therapy Highlights Platform Value - Yahoo Finance
ClearPoint Neuro stock surges on peer’s FDA approval plan By Investing.com - Investing.com Canada
$ClearPoint Neuro (CLPT.US)$ LG…time to see some better DDs…🏎👍🏿🔥🔥🔥🔥🔥🏁 - Moomoo
$ClearPoint Neuro (CLPT.US)$ small bag for a small pop over $20 - Moomoo
Why is Clearpoint Neuro stock surging today? - Investing.com
ClearPoint Neuro Q1 2026 Earnings: EPS Misses Estimates Amid Operational ChallengesShort-Term Outlook - newsline.com
CLPT Q1 2026 Earnings: EPS Misses Estimates While Stock Holds SteadyEarnings Surprise Stocks - dars.gov.et
Analysts Offer Insights on Healthcare Companies: Artivion (AORT), Incyte (INCY) and ClearPoint Neuro (CLPT) - The Globe and Mail
Stifel reiterates Clearpoint Neuro stock rating on neurosurgery platform By Investing.com - Investing.com India
Stifel reiterates Clearpoint Neuro stock rating on neurosurgery platform - Investing.com
ClearPoint Neuro (CLPT) director exercises options and withholds shares for taxes - Stock Titan
Why (CLPT) Price Action Is Critical for Tactical Trading - Stock Traders Daily
ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint - ACCESS Newswire
Director at ClearPoint Neuro (NASDAQ: CLPT) sells shares to cover taxes - Stock Titan
2.62%
2.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):